What is Inductafil

	A unique graft material derived from trabecular bone that has compressible and elastic, sponge-like properties.
	Our demineralization process* revolutionizes the handling properties of bone while maintaining natural growth factors.
	It has the open, porous structure of cancellous bone while being also compressible and elastic, with the properties of a sponge.
	With the ability to be compressed to 1/3 of its original size in order to fit a space, it then springs back to fill the void without losing its original strength or shape. Inductafil is a perfect solution for filling a variety of bone voids.
	When implanted, it may induce at the locus of the implant (the full developmental cascade of endochondral bone formation) including vascularization, mineralization, and bone marrow differentiation.
	Available in several sizes and may be used with osteogeneic promoters such as bone marrow or platelet rich plasma.
	It is processed by a fully accredited American Association of Tissue Banks (“AATB”) Tissue Bank and Processing Facility complies with FDA 21 CFR 1270 and 1271. Inductafil is comprised of 100% donor tissue from federally licensed Organ Procurement Organizations (OPO’s) and other AATB accredited donor sources.

Demineralized bone matrices are prepared by acid extraction of allograft bone, resulting inloss of most of the mineralized component but retention ofcollagen and noncollagenous proteins, including growth factors.The efficacy of a demineralized bone matrix (DBM) as a bonegraft substitute or extender may be related to the total amount of bone morphogenetic protein (BMP) present, and the ratios of the different BMPs present.BMPs belong to the transforming growth factor (TGF) superfamily of proteins.